| Autor: |
Burns A; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Alsolami R; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK.; Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.; King Abdulaziz University, Faculty of Applied Medical Sciences, Jeddah, Saudi Arabia., Becq J; Illumina Cambridge Ltd, Saffron Walden, UK., Stamatopoulos B; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK., Timbs A; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK., Bruce D; Department of Oncology, University of Oxford, Oxford, UK.; Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, UK., Robbe P; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Vavoulis D; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Clifford R; Department of Oncology, University of Oxford, Oxford, UK., Cabes M; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK., Dreau H; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK., Taylor J; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Knight SJL; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Mansson R; Center for Hematology and Regenerative Medicine Huddinge, Karolinska Institute, Stockholm, Sweden., Bentley D; Illumina Cambridge Ltd, Saffron Walden, UK., Beekman R; Biomedical Epigenomics Group, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Martín-Subero JI; Biomedical Epigenomics Group, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Campo E; Hematopathology Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Ridout KE; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Schuh A; Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK. anna.schuh@oncology.ox.ac.uk.; Department of Oncology, University of Oxford, Oxford, UK. anna.schuh@oncology.ox.ac.uk.; Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, UK. anna.schuh@oncology.ox.ac.uk. |
Full text from SpringerLink